Quote For Endo Pharmaceuticals Holdings Inc ENDP.O
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
30 Nov 2009
22.03USD
$22.03
30 Nov 2009
-2.52%
$22.60
$22.52
1,225,283
$22.62
$22.01
$26.14
$15.75
0.49
768,909
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Kimmel, Roger |
Chairman of the Board |
-- |
| Holveck, David |
President, Chief Executive Officer, Director |
1,960,615 |
| Levin, Alan |
Chief Financial Officer, Executive Vice President |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$2,650.06 |
| Shares Outstanding (Mil.) |
117.26 |
| Float (Mil.) |
115.10 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
0.00 |
| |
| Financial Strength |
| Quick Ratio |
2.85 |
| Current Ratio |
1.93 |
| LT Debt/Equity |
23.67 |
| Total Debt/Equity |
23.67 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
13.69 |
| Price/Sales(TTM) |
1.87 |
| Price/Book(TTM) |
1.97 |
| Price/Cash Flow(TTM) |
10.04 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$1.66 |
| Sales(TTM) |
$12.08 |
| Book Value(MRQ) |
$11.47 |
| Cash Flow(TTM) |
$2.25 |
| Cash(MRQ) |
$4.07 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
16.25 |
| Return on Assets(TTM) |
8.88 |
| Return on Investment(TTM) |
11.54 |
| |
|
| Margins |
| Gross Margin(TTM) % |
75.04 |
| Operating Margin(TTM) % |
24.26 |
| Profit Margin(TTM) % |
13.65 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives